Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Garg

Showing results (271-280 of 352) with videos related to

Pageof 36
Sort By:
Journal of Clinical Pharmacology|December 21, 2018
Development of a Subcutaneous Fixed-Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose-Finding StudyWhitney P Kirschbrown, Chris Wynne, Matts Kågedal, et al.
Journal for Immunotherapy of Cancer|November 23, 2019
Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancerColby S Shemesh, Pascal Chanu, Kris Jamsen, et al.
International Archives of Otorhinolaryngology|October 12, 2017
Evaluation of the Efficacy and Tolerability of Oral Ciprofloxacin used in the Comprehensive Treatment of External Bacterial Otitis: An Observational Prospective StudyAlexander Vladimirovich Gurov, Andrey Ivanovich Kriukov, Vera Yakovlevna Kunelskaya, et al.
JAMA Dermatology|July 30, 2025
Risk of New-Onset and Recurrent Depression and Anxiety Among Patients With Hidradenitis SuppurativaNikolaj Holgersen, Nana Aviaaja Lippert Rosenø, Valdemar Wendelboe Nielsen, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
Pustular Psoriasis and Associated Musculoskeletal DisordersKristina Callis Duffin, Hervé Bachelez, Philip J Mease, et al.
JAMA Dermatology|March 11, 2026
Hidradenitis Suppurativa and Risk of Self-Harm and SuicideNikolaj Holgersen, Nana Aviaaja Lippert Rosenø, Valdemar Wendelboe Nielsen, et al.
Dermatology and Therapy|December 30, 2022
Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims DataAmit Garg, Haley B Naik, Afsaneh Alavi, et al.
Biopharmaceutics & Drug Disposition|October 28, 2011
Lack of an effect of anacetrapib on the pharmacokinetics of digoxin in healthy subjectsRajesh Krishna, Daria Stypinski, Melissa Ali, et al.
BMJ Open|February 22, 2017
Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomesLinnea Thorlacius, John R Ingram, Amit Garg, et al.
Journal of the American Medical Informatics Association : JAMIA|August 25, 2006
McMaster PLUS: a cluster randomized clinical trial of an intervention to accelerate clinical use of evidence-based information from digital librariesR Brian Haynes, Jennifer Holland, Chris Cotoi, et al.
Pageof 36

Showing results (271-280 of 352) with videos related to

Sort By:
Pageof 36
Journal of Clinical Pharmacology|December 21, 2018
Development of a Subcutaneous Fixed-Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose-Finding StudyWhitney P Kirschbrown, Chris Wynne, Matts Kågedal, et al.
Journal for Immunotherapy of Cancer|November 23, 2019
Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancerColby S Shemesh, Pascal Chanu, Kris Jamsen, et al.
International Archives of Otorhinolaryngology|October 12, 2017
Evaluation of the Efficacy and Tolerability of Oral Ciprofloxacin used in the Comprehensive Treatment of External Bacterial Otitis: An Observational Prospective StudyAlexander Vladimirovich Gurov, Andrey Ivanovich Kriukov, Vera Yakovlevna Kunelskaya, et al.
JAMA Dermatology|July 30, 2025
Risk of New-Onset and Recurrent Depression and Anxiety Among Patients With Hidradenitis SuppurativaNikolaj Holgersen, Nana Aviaaja Lippert Rosenø, Valdemar Wendelboe Nielsen, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
Pustular Psoriasis and Associated Musculoskeletal DisordersKristina Callis Duffin, Hervé Bachelez, Philip J Mease, et al.
JAMA Dermatology|March 11, 2026
Hidradenitis Suppurativa and Risk of Self-Harm and SuicideNikolaj Holgersen, Nana Aviaaja Lippert Rosenø, Valdemar Wendelboe Nielsen, et al.
Dermatology and Therapy|December 30, 2022
Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims DataAmit Garg, Haley B Naik, Afsaneh Alavi, et al.
Biopharmaceutics & Drug Disposition|October 28, 2011
Lack of an effect of anacetrapib on the pharmacokinetics of digoxin in healthy subjectsRajesh Krishna, Daria Stypinski, Melissa Ali, et al.
BMJ Open|February 22, 2017
Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomesLinnea Thorlacius, John R Ingram, Amit Garg, et al.
Journal of the American Medical Informatics Association : JAMIA|August 25, 2006
McMaster PLUS: a cluster randomized clinical trial of an intervention to accelerate clinical use of evidence-based information from digital librariesR Brian Haynes, Jennifer Holland, Chris Cotoi, et al.
Pageof 36